Human Macrophage Metalloelastase Worsens the Prognosis of Pancreatic Cancer

Abstract

ObjectiveTo evaluate the role of human macrophage metalloelastase (HME) in pancreatic cancer. Summary Background DataHME, a member of the human matrix metalloproteinase family, possesses elastolytic activity and is critical for the degradation of extracellular matrix proteins. Inasmuch as tumor invasion and metastasis formation require lysis of extracellular matrix, HME plays a critical role in both processes. MethodsHME expression was analyzed by Northern blot analysis, reverse transcriptase-polymerase chain reaction, Western blot analysis, and immunohistochemistry in 39 pancreatic cancer tissues and 13 normal controls. The molecular data were related to clinicopathologic parameters and patient survival. ResultsIn human pancreatic cancer, overexpression of HME mRNA was present in 25 of 39 pancreatic cancer tissues (64%) and in five pancreatic cancer cell lines. In contrast, low levels of HME mRNA expression were present in 13 normal pancreatic tissues samples. By Western blot analysis, high levels of HME were found in pancreatic cancer tissues and in the pancreatic cancer cell lines compared with the normal controls. Fifty-six percent of the cancer samples exhibited HME immunoreactivity in the cancer cells, and 63% in the stromal cells. Analysis of the survival data revealed that patients whose tumors exhibited HME mRNA overexpression lived significantly shorter compared with patients whose tumors did not overexpress HME. No relationship between HME expression and tumor stage, tumor grading, or presence of lymph node metastases was found. ConclusionsThese findings indicate that HME participates in pancreatic cancer progression and that its presence worsens the prognosis. These data suggest a benefit of its inhibition in the treatment of pancreatic cancer.

Endostatin expression in pancreatic tissue is modulated by elastase

“…This circulating elastase is likely to be the inactive proform of pancreatic elastase, which would not thus degrade endostatin. Conversely, pancreatic tumours expressing macrophage metalloelastase have a worse prognosis than those that do not (Balaz et al, 2002). In this instance, we suggest that the elastase is active and degrades endostatin so that angiogenesis can occur as well as promoting invasion.…”

Identification of novel molecular markers for detection of gastric cancer cells in the peripheral blood circulation using genome-wide microarray analysis

“…Two matrix metalloproteinases, MMP7 and MMP12, were among the five marker genes which were newly identified in this study. MMPs are a family of zinc-dependent proteolytic enzymes capable of cleaving extracellular matrix proteins, and the expression of MMPs in cancer tissue has been reported to be associated with the risk of metastasis (32)(33)(34)(35)(36)(37)(38). These two MMPs may play important roles in tumor invasion and the formation of metastasis in gastric cancer.…”

Clinical Significance of Angiogenesis in Gastrointestinal Cancers

“…167 However, a recent study of patients with pancreatic carcinoma found that overexpression of human macrophage metalloelastase was associated with poorer survival. 168 The enzyme might enhance tumor invasion and metastasis by the degradation of extracellular matrix.…”